Takeda Pharmaceutical Company has announced the approval of Helicobacter pylori Gastritis as an additional indication to eradicate Helicobacter pylori using triple therapy with proton pump inhibitor by Japan's Ministry of Health, Labour and ...
Tags: Helicobacter pylori Gastritis, Helicobacter pylori eradication
Abbott has entered into a collaboration agreement with Janssen Biotech and Pharmacyclics to develop a molecular companion diagnostic test for investigational leukemia therapy. Under the agreement, Abbott will leverage its proprietary ...
Tags: leukemia therapy, Abbott, Pharmacyclics
The USFDA has granted priority review designation to ViiV Healthcare's dolutegravir as a candidate with the potential to treat HIV infection in combination with other antiretroviral agents, in adolescents and adults. The dolutegravir new ...
Tags: infection therapy, Healthcare, FDA
Albany Molecular Research (AMRI) and Chai Therapeutics, an affiliate of Bessor Pharma, have signed a licensing deal to develop tubulin inhibitor compound, ALB 109564(a), for cancer treatment. AMRI's ALB 109564(a) is a novel analog ...
Takeda Pharmaceutical has received FDA approval for three new type 2 diabetes therapies Nesina (alogliptin) and fixed-dose combinations Oseni (alogliptin and pioglitazone) and Kazano (alogliptin and metformin HCl). Takeda expects to ...
Tags: FDA, diabetes therapies, Pharmaceuticals
TVM Life Science Ventures VII has made the first investment in Montreal-based Kaneq Bioscience, a spin out company of Kaneq Pharma. Kaneq Bioscience was created for developing a protein tyrosine phosphatase1B (PTP-1B) inhibitor, designed ...
Tags: TVM Life Science, Pharma, Kaneq Pharma
Infiniti is rushing to expand its product portfolio, according to the brand’s global boss, Johan de Nysschen. Following a discussion about Infiniti’s plans to increase its global footprint and brand awareness, de Nysschen ...
Chinese firm Lenovo has overtaken Acer in the volume of EMEA PC sales made by quarter, to become the second biggest PC maker in the region, behind HP. According to figures for the fourth quarter of 2012 from analysts IDC, a sustained ...
Tags: Lenovo, Acer, EMEA PC sales, company news
Telik has announced notification of FDA orphan drug designation to ezatiostat HCL (Telintra) for the treatment of myelodysplastic syndrome (MDS). The novel inhibitor of the enzyme glutathione S-transferase P1 1,Telintra activates Jun ...
Tags: orphan drug, ezatiostat HCL, drug
Santaris Pharma and miRagen Therapeutics have extended their research deal to discover and develop LNA-drugs against disease causing microRNAs. The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field ...
Gilead Sciences, a biopharmaceutical company, has submitted a new drug application (NDA) to the FDA for HIV integrase inhibitor elvitegravir for the treatment-experienced patients. The company provided 96-week data from a pivotal Phase ...
CIO - There's no question, we're at an inflection point in the digitization of our world. In every domain and dimension, the substitution of digital for analog is racing ahead. A couple recent examples illustrate the power of this trend. ...
Tags: digitization, digital, transforming manufacturing, IT, big data
Bristol-Myers Squibb and Pfizer have announced the approval of Eliquis (apixaban) anticoagulant for the prevention of ischemic stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation (NVAF) in Japan. The ...
Tags: Japan, approval, anticoagulant, subanalysis
Giving customers an element of control when it comes to storing their data in the cloud is the key to gaining their trust and, in turn, their patronage. This is the belief of Trend Micro’s solutions architect, Udo Schneider, who ...
Tags: Trend Micro, Encryption, cloud security, Computer Products
Lexicon Pharmaceuticals has won Fast Track status from the US FDA to develop LX1033, an orally-delivered small molecule drug candidate to treat diarrhea-predominant irritable bowel syndrome (IBS-d). Fast Track facilitates the development ...
Tags: Lexicon Pharmaceuticals, small molecule drug candidate